4 Pfuhl P, K？rcher U, H？ring N, et al. Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma[J]. J Pharm Biomed Anal, 2005, 36(5): 1045-1052.
[5]
5 Lauring B, Rosko K, Luo WL, et al. A comparison of the pharmacokinetics of two different formulations of extended-release niacin[J]. Curr Med Res Opin, 2009, 25(1): 15-22.
[6]
6 Zhang P, Sun Y, Shi G, et al. Quantification of niacin and its metabolite nicotinuric acid in human plasma by LC-MS/MS: application to a clinical trial of a fixed dose combination tablet of niacin extended-release/simvastatin (500mg/10mg) in healthy Chinese volunteers[J]. Int J Anal Chem, 2015: 212437.
[7]
7 Liu M, Zhang D, Wang X, et al. Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 904(2): 107-114.
[8]
8 Menon R, Tolbert D, Cefali E. The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet[J]. Biopharm Drug Dispos, 2007, 28(6): 297-306.
14 Liu M, Wang XL, Zhang D, et al. Pharmacokinetics of niacin, simvastatin and their metabolites in healthy Chinese subjects after single and multiple doses of a fixed dose combination tablet of niacin extended release/simvastatin[J]. Drug Res (Stuttg), 2014, 64(6): 296-300.
[15]
15 Wang XL, Liu M, Yang M, et al. Gender differences in pharmacokinetics of a combination tablet of niacin extended-release/simvastatin in healthy Chinese volunteers[J]. Eur J Drug Metab Pharmacokinet, 2014, 39(4): 321-326.
